Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 494501 - 494520 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EG02) everolimus (adm: O) | AFINITOR 5MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | EVEROLIMUS (ANTINEOPLASTIC) 5MG TAB | 4X7 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L01EG02) everolimus (adm: O) | AFINITOR 7.5MG TAB | 1X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | AFINITOR 7.5MG TAB | 1X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | EVEROLIMUS (ANTINEOPLASTIC) 7.5MG TAB | 4X7 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L01EH01) lapatinib (adm: O) | TYKERB 250MG TAB | 150 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EH01) lapatinib (adm: O) | TYKERB 250MG TAB | 150 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG ORAL GRANULES | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG ORAL GRANULES | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 125MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 125MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 150MGX28 (300MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 150MGX28 (300MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX28 (200MG) PKT | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
